Page last updated: 2024-09-05

uk 34787 and 2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid

uk 34787 has been researched along with 2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid in 1 studies

Compound Research Comparison

Studies
(uk 34787)
Trials
(uk 34787)
Recent Studies (post-2010)
(uk 34787)
Studies
(2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid)
Trials
(2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid)
Recent Studies (post-2010) (2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid)
70012200

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blockmans, D; Deckmyn, H; Gresele, P; Vermylen, J1

Other Studies

1 other study(ies) available for uk 34787 and 2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid

ArticleYear
Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 246, Issue:1

    Topics: Adenylyl Cyclases; Adult; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Dinoprostone; Eicosanoic Acids; Enzyme Activation; Female; Humans; Imidazoles; Indoles; Male; Methacrylates; Middle Aged; Platelet Aggregation; Prostaglandins E; Pyridines; Thromboxane-A Synthase

1988